New Influencers + New Rules = New Health Care

As we move into the next century, the pace of the health care business will increase. Only organizations that can anticipate and execute their strategies accordingly will survive. We can foresee some of these changes already: the growing power of consumers to manage their own care; the role of the Internet in changing communication channels; the financial success of lifestyle drugs in the marketplace; the use of smart agents to optimize the selection, purchase, and delivery of personalized heal

Written byLoren Buhle Jr
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

As we move into the next century, the pace of the health care business will increase. Only organizations that can anticipate and execute their strategies accordingly will survive. We can foresee some of these changes already: the growing power of consumers to manage their own care; the role of the Internet in changing communication channels; the financial success of lifestyle drugs in the marketplace; the use of smart agents to optimize the selection, purchase, and delivery of personalized health care; and the challenges of maintaining an affordable "quality of life" for the citizens of the world.

Consumers are playing a stronger role in the health care business, shifting decision-making power toward their own goals and away from the physician and payer. These activist consumers are typically of the post-World War II baby boomer generation--also known as the Me Generation--and make health care decisions for themselves, their children, and their aging ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies